CD38 Recombinant Protein

Description of CD38 Recombinant Protein

General information on CD38 Recombinant Protein:

The cluster of differentiation (CD) system is commonly used as a cellular marker for immunophenotyping. Different types of cells in the immune system can be identified by surface CD molecules related to cellular immune function. More than 32 unique CD groups and subcategories have been identified. Some CD molecules act as important receptors or ligands for cells by initiating a cascade of signals and thereby modifying the behavior of the cell. Some CD proteins are not involved in the cell signaling process, but have other functions, such as cell incorporation. Cluster of differentiation 38 (CD38), also known as ADP ribosyl cyclase, is a glycoprotein that exists on the surface of many immune cells (leukocytes), including CD4 +, CD8 +, B, and natural lethal cells. It has multiple features with ADP ribose cyclase 2 CD157. CD38 is a multifunctional exonuclease that can catalyze the synthesis and hydrolysis of cyclic ribose ADP (cADPR) from NAD + to ribose ADP. It also plays a role in cell adhesion, signal transmission, and calcium signal transduction. CD38 was used as a prognostic marker of leukemia. It can also be used to identify plasma cells.

Daratumumab Biosimilar - Anti-CD38 mAb binds to CD38 Recombinant Protein in indirect ELISA Assay

Immobilized CD38 Recombinant Protein (cat. No.PX-P4081) at 0.5µg/mL (100µL/well) can bind to Daratumumab Biosimilar - Anti-CD38 mAb (cat. No.PX-TA1213) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450